Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population.

Randazzo DM, McSherry F, Herndon JE, Affronti ML, Lipp ES, Flahiff C, Miller E, Woodring S, Boulton S, Desjardins A, Ashley DM, Friedman HS, Peters KB.

Complement Ther Clin Pract. 2019 Aug;36:43-48. doi: 10.1016/j.ctcp.2019.05.002. Epub 2019 May 18.

PMID:
31383442
2.

A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors.

Wood PJ, Strong R, McArthur GA, Michael M, Algar E, Muscat A, Rigby L, Ferguson M, Ashley DM.

Cancer Chemother Pharmacol. 2018 Sep;82(3):493-503. doi: 10.1007/s00280-018-3634-4. Epub 2018 Jul 9.

PMID:
29987369
3.

The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selection.

Muscat AM, Wong NC, Drummond KJ, Algar EM, Khasraw M, Verhaak R, Field K, Rosenthal MA, Ashley DM.

Oncotarget. 2017 Dec 15;9(8):7844-7858. doi: 10.18632/oncotarget.23541. eCollection 2018 Jan 30.

4.

Efficacy of a telephone outcall program to reduce caregiver burden among caregivers of cancer patients [PROTECT]: a randomised controlled trial.

Heckel L, Fennell KM, Reynolds J, Boltong A, Botti M, Osborne RH, Mihalopoulos C, Chirgwin J, Williams M, Gaskin CJ, Ashley DM, Livingston PM.

BMC Cancer. 2018 Jan 8;18(1):59. doi: 10.1186/s12885-017-3961-6.

5.

Comparison of outcomes for cancer patients discussed and not discussed at a multidisciplinary meeting.

Rogers MJ, Matheson L, Garrard B, Maher B, Cowdery S, Luo W, Reed M, Riches S, Pitson G, Ashley DM.

Public Health. 2017 Aug;149:74-80. doi: 10.1016/j.puhe.2017.04.022. Epub 2017 May 31.

PMID:
28575751
6.

Methylation profiling of paediatric pilocytic astrocytoma reveals variants specifically associated with tumour location and predictive of recurrence.

Sexton-Oates A, Dodgshun A, Hovestadt V, Jones DTW, Ashley DM, Sullivan M, MacGregor D, Saffery R.

Mol Oncol. 2018 Aug;12(8):1219-1232. doi: 10.1002/1878-0261.12062. Epub 2018 Jul 6.

7.

A Discrete Choice Experiment to Examine the Preferences of Patients With Cancer and Their Willingness to Pay for Different Types of Health Care Appointments.

Wong SF, Norman R, Dunning TL, Ashley DM, Khasraw M, Hayes TM, Collins I, Lorgelly PK.

J Natl Compr Canc Netw. 2016 Mar;14(3):311-9. Epub 2016 Mar 8.

PMID:
26957617
8.

Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors.

Muscat A, Popovski D, Jayasekara WS, Rossello FJ, Ferguson M, Marini KD, Alamgeer M, Algar EM, Downie P, Watkins DN, Cain JE, Ashley DM.

Clin Cancer Res. 2016 Jul 15;22(14):3560-70. doi: 10.1158/1078-0432.CCR-15-2260. Epub 2016 Feb 26.

9.

Unmet needs and depression among carers of people newly diagnosed with cancer.

Heckel L, Fennell KM, Reynolds J, Osborne RH, Chirgwin J, Botti M, Ashley DM, Livingston PM.

Eur J Cancer. 2015 Sep;51(14):2049-57. doi: 10.1016/j.ejca.2015.06.129. Epub 2015 Jul 21.

10.

Retrospective analysis of cancer survival across South-Western Victoria in Australia.

Wong SF, Matheson L, Morrissy K, Pitson G, Ashley DM, Khasraw M, Lorgelly PK, Henry MJ.

Aust J Rural Health. 2016 Apr;24(2):79-84. doi: 10.1111/ajr.12203. Epub 2015 Jun 29.

PMID:
26122852
11.

Paediatric leukaemia DNA methylation profiling using MBD enrichment and SOLiD sequencing on archival bone marrow smears.

Wong NC, Meredith GD, Marnellos G, Dudas M, Parkinson-Bates M, Halemba MS, Chatterton Z, Maksimovic J, Ashley DM, Mechinaud F, Craig JM, Saffery R.

Gigascience. 2015 Mar 18;4:11. doi: 10.1186/s13742-015-0050-0. eCollection 2015.

12.

A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma.

Shou Y, Robinson DM, Amakye DD, Rose KL, Cho YJ, Ligon KL, Sharp T, Haider AS, Bandaru R, Ando Y, Geoerger B, Doz F, Ashley DM, Hargrave DR, Casanova M, Tawbi HA, Rodon J, Thomas AL, Mita AC, MacDonald TJ, Kieran MW.

Clin Cancer Res. 2015 Feb 1;21(3):585-93. doi: 10.1158/1078-0432.CCR-13-1711. Epub 2014 Dec 3.

13.

A protocol for a discrete choice experiment: understanding preferences of patients with cancer towards their cancer care across metropolitan and rural regions in Australia.

Wong SF, Norman R, Dunning TL, Ashley DM, Lorgelly PK.

BMJ Open. 2014 Oct 24;4(10):e006661. doi: 10.1136/bmjopen-2014-006661.

14.

Characteristics of cancer diagnoses and staging in South Western Victoria: a rural perspective.

Banks P, Matheson LM, Morrissy K, Olesen I, Pitson G, Chapman A, Ashley DM, Henry MJ.

Aust J Rural Health. 2014 Oct;22(5):257-63. doi: 10.1111/ajr.12112.

PMID:
25303418
15.

Validation of DNA methylation biomarkers for diagnosis of acute lymphoblastic leukemia.

Chatterton Z, Burke D, Emslie KR, Craig JM, Ng J, Ashley DM, Mechinaud F, Saffery R, Wong NC.

Clin Chem. 2014 Jul;60(7):995-1003. doi: 10.1373/clinchem.2013.219956. Epub 2014 May 14.

16.

Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry.

Gupta S, Tran T, Luo W, Phung D, Kennedy RL, Broad A, Campbell D, Kipp D, Singh M, Khasraw M, Matheson L, Ashley DM, Venkatesh S.

BMJ Open. 2014 Mar 17;4(3):e004007. doi: 10.1136/bmjopen-2013-004007.

17.

Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.

Orme LM, Babl FE, Barnes C, Barnett P, Donath S, Ashley DM.

Pediatr Blood Cancer. 2014 Aug;61(8):1427-33. doi: 10.1002/pbc.25012. Epub 2014 Mar 6.

PMID:
24604835
18.

Epigenetic deregulation in pediatric acute lymphoblastic leukemia.

Chatterton Z, Morenos L, Mechinaud F, Ashley DM, Craig JM, Sexton-Oates A, Halemba MS, Parkinson-Bates M, Ng J, Morrison D, Carroll WL, Saffery R, Wong NC.

Epigenetics. 2014 Mar;9(3):459-67. doi: 10.4161/epi.27585. Epub 2014 Jan 6.

19.

Efficacy and cost-effectiveness of an outcall program to reduce carer burden and depression among carers of cancer patients [PROTECT]: rationale and design of a randomized controlled trial.

Livingston PM, Osborne RH, Botti M, Mihalopoulos C, McGuigan S, Heckel L, Gunn K, Chirgwin J, Ashley DM, Williams M.

BMC Health Serv Res. 2014 Jan 6;14:5. doi: 10.1186/1472-6963-14-5.

20.

The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts.

Bandopadhayay P, Jabbour AM, Riffkin C, Salmanidis M, Gordon L, Popovski D, Rigby L, Ashley DM, Watkins DN, Thomas DM, Algar E, Ekert PG.

BMC Cancer. 2013 Dec 9;13:585. doi: 10.1186/1471-2407-13-585.

21.

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.

Gottardo NG, Hansford JR, McGlade JP, Alvaro F, Ashley DM, Bailey S, Baker DL, Bourdeaut F, Cho YJ, Clay M, Clifford SC, Cohn RJ, Cole CH, Dallas PB, Downie P, Doz F, Ellison DW, Endersby R, Fisher PG, Hassall T, Heath JA, Hii HL, Jones DT, Junckerstorff R, Kellie S, Kool M, Kotecha RS, Lichter P, Laughton SJ, Lee S, McCowage G, Northcott PA, Olson JM, Packer RJ, Pfister SM, Pietsch T, Pizer B, Pomeroy SL, Remke M, Robinson GW, Rutkowski S, Schoep T, Shelat AA, Stewart CF, Sullivan M, Taylor MD, Wainwright B, Walwyn T, Weiss WA, Williamson D, Gajjar A.

Acta Neuropathol. 2014 Feb;127(2):189-201. doi: 10.1007/s00401-013-1213-7. Epub 2013 Nov 22.

22.

Emerging pharmacotherapy for cancer patients with cognitive dysfunction.

Davis J, Ahlberg FM, Berk M, Ashley DM, Khasraw M.

BMC Neurol. 2013 Oct 24;13:153. doi: 10.1186/1471-2377-13-153. Review.

23.

Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells.

Cain JE, McCaw A, Jayasekara WS, Rossello FJ, Marini KD, Irving AT, Kansara M, Thomas DM, Ashley DM, Watkins DN.

Sarcoma. 2013;2013:608964. doi: 10.1155/2013/608964. Epub 2013 Feb 28.

24.

Case report of interstitial nephritis induced by bevacizumab therapy for glioblastoma multiforme.

Lomax AJ, Hill PA, Ashley DM.

J Oncol Pharm Pract. 2013 Dec;19(4):365-8. doi: 10.1177/1078155212466421. Epub 2012 Dec 12.

PMID:
23235917
25.

Enhanced lithium-induced brain recovery following cranial irradiation is not impeded by inflammation.

Malaterre J, McPherson CS, Denoyer D, Lai E, Hagekyriakou J, Lightowler S, Shudo K, Ernst M, Ashley DM, Short JL, Wheeler G, Ramsay RG.

Stem Cells Transl Med. 2012 Jun;1(6):469-79. doi: 10.5966/sctm.2011-0046. Epub 2012 May 30.

26.

Predictors of acute and posttraumatic stress symptoms in parents following their child's cancer diagnosis.

McCarthy MC, Ashley DM, Lee KJ, Anderson VA.

J Trauma Stress. 2012 Oct;25(5):558-66. doi: 10.1002/jts.21745. Epub 2012 Oct 10.

PMID:
23055298
27.

Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934.

Ashley DM, Merchant TE, Strother D, Zhou T, Duffner P, Burger PC, Miller DC, Lyon N, Bonner MJ, Msall M, Buxton A, Geyer R, Kun LE, Coleman L, Pollack IF.

J Clin Oncol. 2012 Sep 10;30(26):3181-6. doi: 10.1200/JCO.2010.34.4341. Epub 2012 Jul 30.

28.

Feasibility of neurobehavioral screening following diagnosis of pediatric cancer.

Pejnovic LP, De Luca CR, Gentle E, Anson K, Ashley DM, Anderson VA, McCarthy MC.

Pediatr Blood Cancer. 2012 Aug;59(2):295-300. doi: 10.1002/pbc.24056. Epub 2012 Jan 11.

PMID:
22238124
29.

High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival.

Birks DK, Donson AM, Patel PR, Dunham C, Muscat A, Algar EM, Ashley DM, Kleinschmidt-Demasters BK, Vibhakar R, Handler MH, Foreman NK.

Neuro Oncol. 2011 Dec;13(12):1296-307. doi: 10.1093/neuonc/nor140. Epub 2011 Sep 23.

30.

ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy.

Bandopadhayay P, Hassall TE, Rosenfeld JV, Wheeler GC, Downie PA, Kirby ML, Cohn RJ, Sullivan MJ, Ashley DM.

Pediatr Blood Cancer. 2011 Jul 1;56(7):1055-61. doi: 10.1002/pbc.22942. Epub 2011 Feb 4.

PMID:
21298769
31.

Rapid detection of SMARCB1 sequence variation using high resolution melting.

Dagar V, Chow CW, Ashley DM, Algar EM.

BMC Cancer. 2009 Dec 13;9:437. doi: 10.1186/1471-2407-9-437.

32.

Neuropsychological impact of treatment of brain tumors.

De Luca CR, Conroy R, McCarthy MC, Anderson VA, Ashley DM.

Cancer Treat Res. 2009;150:277-96. doi: 10.1007/b109924_17. Review. No abstract available.

PMID:
19834674
33.

Measuring psychosocial risk in families caring for a child with cancer: the Psychosocial Assessment Tool (PAT2.0).

McCarthy MC, Clarke NE, Vance A, Ashley DM, Heath JA, Anderson VA.

Pediatr Blood Cancer. 2009 Jul;53(1):78-83. doi: 10.1002/pbc.22007.

PMID:
19343796
34.

Gender differences in the psychosocial experience of parents of children with cancer: a review of the literature.

Clarke NE, McCarthy MC, Downie P, Ashley DM, Anderson VA.

Psychooncology. 2009 Sep;18(9):907-15. doi: 10.1002/pon.1515. Review.

PMID:
19319828
35.

Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.

Algar EM, Muscat A, Dagar V, Rickert C, Chow CW, Biegel JA, Ekert PG, Saffery R, Craig J, Johnstone RW, Ashley DM.

PLoS One. 2009;4(2):e4482. doi: 10.1371/journal.pone.0004482. Epub 2009 Feb 16.

36.

Costimulation molecule expression and subset distribution of blood dendritic cells in normal children and newly diagnosed pediatric leukemia and lymphoma patients.

Caruso DA, Fraser S, Hardy K, Amor G, Helmich JJ, Ashley DM.

Exp Hematol. 2008 Dec;36(12):1691-703. doi: 10.1016/j.exphem.2008.07.003. Epub 2008 Sep 21.

PMID:
18809238
37.

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.

Ashley DM, Riffkin CD, Lovric MM, Mikeska T, Dobrovic A, Maxwell JA, Friedman HS, Drummond KJ, Kaye AH, Gan HK, Johns TG, Hawkins CJ.

Br J Cancer. 2008 Jul 22;99(2):294-304. doi: 10.1038/sj.bjc.6604459. Epub 2008 Jul 1. Erratum in: Br J Cancer. 2009 Mar 24;100(6):1012.

38.

Brain stem gliomas: patterns of care in Victoria from 1998-2000.

Rosenthal MA, Ashley DM, Drummond KJ, Dally M, Murphy M, Cher L, Thursfield V, Giles GG.

J Clin Neurosci. 2008 Mar;15(3):237-40. doi: 10.1016/j.jocn.2007.04.008. Epub 2008 Jan 15.

PMID:
18226529
39.

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.

Merchant TE, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, Ashley DM, Sexton M, Kellie SJ, Ahern V, Gajjar A.

Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):782-7. Epub 2007 Sep 24.

40.

Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.

Ashton LJ, Murray JE, Haber M, Marshall GM, Ashley DM, Norris MD.

Pharmacogenet Genomics. 2007 Sep;17(9):709-17.

PMID:
17700360
41.

Temozolomide in pediatric low-grade glioma.

Khaw SL, Coleman LT, Downie PA, Heath JA, Ashley DM.

Pediatr Blood Cancer. 2007 Nov;49(6):808-11.

PMID:
17588234
42.

Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas.

Moghrabi A, Friedman HS, Ashley DM, Bottom KS, Kerby T, Stewart E, Bruggers C, Provenzale JM, Champagne M, Hershon L, Watral M, Ryan J, Rasheed K, Lovell S, Korones D, Fuchs H, George T, McLendon RE, Friedman AH, Buckley E, Longee DC.

Neurosurg Focus. 1998 Apr 15;4(4):e3.

PMID:
17168503
43.

Use of the Omaha System data to validate Medicare required outcomes in home care.

Westra BL, Solomon D, Ashley DM.

J Healthc Inf Manag. 2006 Summer;20(3):88-94.

PMID:
16903666
45.

Human Bcl-2 cannot directly inhibit the Caenorhabditis elegans Apaf-1 homologue CED-4, but can interact with EGL-1.

Jabbour AM, Puryer MA, Yu JY, Lithgow T, Riffkin CD, Ashley DM, Vaux DL, Ekert PG, Hawkins CJ.

J Cell Sci. 2006 Jun 15;119(Pt 12):2572-82. Epub 2006 May 30.

46.

Adolescent and young adult cancer: a revolution in evolution?

Thomas DM, Seymour JF, O'Brien T, Sawyer SM, Ashley DM.

Intern Med J. 2006 May;36(5):302-7.

PMID:
16650195
47.

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.

Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, Taylor MD, Curran T, Gajjar A, Gilbertson RJ.

J Clin Oncol. 2006 Apr 20;24(12):1924-31. Epub 2006 Mar 27.

PMID:
16567768
48.

Adverse hypersensitivity reactions to mesna as adjunctive therapy for cyclophosphamide.

Khaw SL, Downie PA, Waters KD, Ashley DM, Heath JA.

Pediatr Blood Cancer. 2007 Sep;49(3):341-3. Review.

PMID:
16333822
49.

Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.

Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A.

J Clin Oncol. 2005 Aug 20;23(24):5511-9.

PMID:
16110011
50.

Caspase 8 is absent or low in many ex vivo gliomas.

Ashley DM, Riffkin CD, Muscat AM, Knight MJ, Kaye AH, Novak U, Hawkins CJ.

Cancer. 2005 Oct 1;104(7):1487-96.

Supplemental Content

Loading ...
Support Center